R. Stewart

发表

Predictive factors on outcomes in metaplastic breast cancer

B. Calhoun, C. Shah, Shree Agrawal, 2017, Breast Cancer Research and Treatment.

166MO Datopotamab deruxtecan (Dato-DXd) + durvalumab (D) as first-line (1L) treatment for unresectable locally advanced/metastatic triple-negative breast cancer (a/mTNBC): Initial results from BEGONIA, a phase Ib/II study

J. Jassem, P. Wysocki, P. Schmid, 2022, Annals of Oncology.

Metaplastic Breast Cancer: A Clinicopathologic Correlation of Histologic Subtype on Disease Control

B. Calhoun, Shree Agrawal, H. Moore, 2015 .

Intraoperative Radiation for Breast Cancer with Intrabeam™: Factors Associated with Decreased Operative Times in Patients Having IORT for Breast Cancer

C. Shah, S. Grobmyer, D. Radford, 2017, Front. Oncol..

Retrospective study of the efficacy and safety of neoadjuvant docetaxel, carboplatin, trastuzumab/pertuzumab (TCH-P) in nonmetastatic HER2-positive breast cancer

B. Calhoun, J. Abraham, S. Grobmyer, 2016, Breast Cancer Research and Treatment.